服务平台拥有丰富的技术服务经验,一流的仪器设备,先进的检测手段和严格的质量控制体系,力求为全球药物研发机构提供优质高效的技术服务

  • Spike S1 RBD (V483A), Avi-His-tag (SARS-CoV-2)

    规格:100 µg

    产品介绍 SARS-CoV-2 Spike S1 receptor binding domain (RBD), also known as SARS-CoV-2 Spike 1 RBD, novel coronavirus Spike 1 RBD and nCoV Spike 1 RBD, GenBank Accession No. QHD43416.1, a.a. 319-541 with a V367F mutation and a with C-terminal Avi-His-tag, expressed in a HEK293 cell expression system. MW= 28 kDa. This protein runs at a higher M.W. by SDS-PAGE due to glycosylation.

    询价
  • KRAS (G12R), Isoform A, His-Tag (E. coli-derived)

    规格:1 mg

    产品介绍 Human KRAS also known as C-K-RAS, CFC2, and K-RAS2A, GenBank Accession No. NM_033360, a.a. 2-186, with G12R mutation and N-terminal His-tag, expressed in an E. coli expression system. MW=23 kDa.

    询价
  • KRAS (G12R), Isoform A, His-Tag (E. coli-derived)

    规格:100 µg

    产品介绍 Human KRAS also known as C-K-RAS, CFC2, and K-RAS2A, GenBank Accession No. NM_033360, a.a. 2-186, with G12R mutation and N-terminal His-tag, expressed in an E. coli expression system. MW=23 kDa.

    询价
  • Anti-CD20-Anti-CD3 Bispecific Antibody

    规格:100 µg

    背景介绍 CD20 (MS4A1) is a glycosylated phosphoprotein expressed on the cell surface of B cells. Although the functional significance of CD20 is not clear, and CD20 has no known ligands, CD20 has been shown to regulate intracellular calcium levels. CD20 is a highly attractive target antigen for immunotherapy because it is expressed in more than 90% of patients with B-cell lymphoma. First approved in 1997, Rituximab (Rituxan) is a chimeric monoclonal antibody targeting CD20 and has been classified by the World Health Organization as an "Essential Medicine". Since then, additional monoclonal antibodies against CD20 have been approved or are being tested in clinical trials for the treatment of multiple sclerosis (MS), chronic lymphocytic leukemia (CLL), follicular lymphoma, diffuse large B cell lymphoma (DLBCL), rheumatoid arthritis, non-Hodgkin's lymphoma, systemic lupus erythematosus, and myalgic encephalomyelitis (chronic fatigue syndrome). 产品介绍 Anti-CD20-Anti-CD3 Fc format bispecific antibody is a purified recombinant human bispecific antibody with T cell Engager. This bispecific antibody has been tested for specific activity in the functional reporter assay using NFAT-luc reporter Jurkat cell line (BPS Bioscience #60621) in the presence of CD20-CHO cells (BPS Bioscience #79624-H).

    询价
  • Anti-CD20-Anti-CD3 Bispecific Antibody

    规格:50 µg

    背景介绍 CD20 (MS4A1) is a glycosylated phosphoprotein expressed on the cell surface of B cells. Although the functional significance of CD20 is not clear, and CD20 has no known ligands, CD20 has been shown to regulate intracellular calcium levels. CD20 is a highly attractive target antigen for immunotherapy because it is expressed in more than 90% of patients with B-cell lymphoma. First approved in 1997, Rituximab (Rituxan) is a chimeric monoclonal antibody targeting CD20 and has been classified by the World Health Organization as an "Essential Medicine". Since then, additional monoclonal antibodies against CD20 have been approved or are being tested in clinical trials for the treatment of multiple sclerosis (MS), chronic lymphocytic leukemia (CLL), follicular lymphoma, diffuse large B cell lymphoma (DLBCL), rheumatoid arthritis, non-Hodgkin's lymphoma, systemic lupus erythematosus, and myalgic encephalomyelitis (chronic fatigue syndrome). 产品介绍 Anti-CD20-Anti-CD3 Fc format bispecific antibody is a purified recombinant human bispecific antibody with T cell Engager. This bispecific antibody has been tested for specific activity in the functional reporter assay using NFAT-luc reporter Jurkat cell line (BPS Bioscience #60621) in the presence of CD20-CHO cells (BPS Bioscience #79624-H).

    询价
  • NSP8, His-tag (SARS-CoV-2)

    规格:1 mg

    产品介绍 SARS-CoV-2 nonstructural protein 8 (NSP8), Genbank Accession No.: YP 009725304.1, a.a. 1-198(full length), with C-terminal His-tag, expressed in an E. coli expression system. MW= 23 kDa.

    询价
  • NSP8, His-tag (SARS-CoV-2)

    规格:100 µg

    产品介绍 SARS-CoV-2 nonstructural protein 8 (NSP8), Genbank Accession No.: YP 009725304.1, a.a. 1-198(full length), with C-terminal His-tag, expressed in an E. coli expression system. MW= 23 kDa.

    询价
  • NSP7, His-tag (SARS-CoV-2)

    规格:1 mg

    产品介绍 SARS-CoV-2 nonstructural protein 7 (NSP7), Genbank Accession No.: YP_009742614, a.a. 1-84(full length), with C-terminal His-tag, expressed in an E. coli expression system. MW= 10 kDa.

    询价
  • NSP7, His-tag (SARS-CoV-2)

    规格:100 µg

    产品介绍 SARS-CoV-2 nonstructural protein 7 (NSP7), Genbank Accession No.: YP_009742614, a.a. 1-84(full length), with C-terminal His-tag, expressed in an E. coli expression system. MW= 10 kDa.

    询价
目前在第230页, 共有451页, 共有4056条记录 第一页 上一页 228229230231232 下一页 最后一页 跳转到
  • 电话:021-54935173
  • 邮箱:marketing@shengzhaobio.com
  • 地址:上海市闵行区罗阳路168号c座305室